CD8A and cancer: To characterize GA1CAR as a versatile universal system capable of targeting multiple antigens on cancer cells with high selectivity and efficacy, we used immortalized and primary human CD8+ T cells alongside breast and ovarian cancer cell lines expressing various endogenous surface antigens.